Key facts
- It has raised $760K; the latest was Seed Round ($750K) in Oct 2025.
- Notable investors include University of Toronto, University of Toronto Entrepreneurship, YSpace (Toronto), Black Entrepreneurship Alliance, Black Founders Network — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Kare Chemical Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Kare Chemical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kare Chemical Technologies
Operator of a chemical and pharmaceutical technology company intended to develop catalytic processes for the commercial production of cannabinoids as active pharmaceutical ingredients. The company specializes in the research, development and commercialization of catalysts, precursors and industrial processes to develop a proprietary catalytic process to make cannabinoids from orange peel, enabling pharmaceutical companies with stability of supply and control over the quality and scalability of the commercial production of cannabinoids as active ingredients.
- Sector
- Healthcare
- HQ
- Mississauga, Canada
- Founded
- 2020
- Employees
- 3
- Website
- karechem.com/
- Ownership
- Privately Held (backing)
Kare Chemical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kare Chemical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kare Chemical Technologies in its N-PORT filings yet. We sweep new filings monthly.